David Nassif

David Nassif

Directeur Général chez SIO GENE THERAPIES INC.

70 ans
Health Technology
Consumer Services
Retail Trade

Profil

David W.
Nassif
currently works at Sio Gene Therapies, Inc., as CEO, CFO, Director, CAO & General Counsel from 2022 and Pharvaris NV, as Chief Financial Officer & Secretary from 2024.
Mr. Nassif also formerly worked at Cypros Pharmaceutical Corp., as Chief Financial Officer & Senior Vice President from 1993 to 1999, Zaldiva, Inc., as Chief Financial Officer, Zogenix, Inc., as CFO, Secretary, Treasurer & Executive VP in 2010, Amphastar Pharmaceuticals, Inc., as Chief Financial Officer & SVP-Global Licensing from 2002 to 2006, RealAge, Inc., as Chief Financial Officer & Senior Vice President from 2000 to 2001, Strategic Consulting Services, as Principal from 2001 to 2002, Strategic Consulting Services, as Principal in 2006, Histogen, Inc., as President & Chief Financial Officer from 2011 to 2014, SteadyMed Ltd., as Chief Financial Officer & Executive Vice President from 2015 to 2019, and Axovant Sciences, Inc., as Chief Financial Officer from 2019 to 2020.
Mr. Nassif received his undergraduate degree from the University of Virginia and graduate degree from the University of Virginia School of Law.

Postes actifs de David Nassif

SociétésPosteDébut
SIO GENE THERAPIES INC. Directeur Général 31/01/2022
PHARVARIS N.V. Directeur Financier/CFO 15/04/2024
Tous les postes actifs de David Nassif

Anciens postes connus de David Nassif

SociétésPosteFin
Directeur Financier/CFO 01/12/2020
STEADYMED LTD Directeur Financier/CFO 30/06/2019
Directeur Financier/CFO 01/09/2014
ZOGENIX, INC. Directeur Financier/CFO 02/03/2010
Strategic Consulting Services Corporate Officer/Principal 01/10/2006
Voir l'expérience en détail de David Nassif

Formation de David Nassif

University of Virginia Undergraduate Degree
University of Virginia School of Law Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de David Nassif

Relations

77

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
AMPHASTAR PHARMACEUTICALS, INC.

Health Technology

PHARVARIS N.V.

Health Technology

Entreprise privées9
Cypros Pharmaceutical Corp.

Health Technology

Retail Trade

Health Technology

Technology Services

Strategic Consulting Services

Health Services

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. David Nassif